Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.61 $216,399 - $660,016
-1,081,995 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$0.48 - $0.74 $114,550 - $176,598
238,647 Added 28.3%
1,081,995 $671,000
Q4 2021

Feb 01, 2022

BUY
$0.7 - $1.94 $377,020 - $1.04 Million
538,601 Added 176.74%
843,348 $589,000
Q3 2021

Nov 12, 2021

BUY
$1.82 - $5.71 $554,639 - $1.74 Million
304,747 New
304,747 $561,000
Q2 2021

Aug 13, 2021

SELL
$5.22 - $7.33 $164,978 - $231,664
-31,605 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$4.0 - $10.28 $193,512 - $497,325
-48,378 Reduced 60.49%
31,605 $205,000
Q4 2020

Feb 16, 2021

BUY
$2.43 - $4.68 $194,358 - $374,320
79,983 New
79,983 $294,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.